business
CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp
A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.
Read full story on Forbes → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Forbes alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop